Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. netherlands
  4. tumor activity
Show results for
Products

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Netherlands
Brands

  • alomfilimab
  • pelabresib
  • tulmimetostat

Tumor Activity Equipment Supplied In Netherlands

3 equipment items found
In NetherlandsAvailable In NetherlandsNear Netherlands

Pelabresib - Model CPI-0610 - Investigational Selective Small-Molecule

Pelabresib - Model CPI-0610 - Investigational Selective Small-Molecule

Manufactured by:MorphoSys AG   based inPlanegg, GERMANY
Pelabresib (CPI-0610) is an investigational selective small-molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. The compound has demonstrated a wide therapeutic window, with activity seen at a 48 mg ...
CONTACT SUPPLIER

Alomfilimab - Model SAR445256 (Formerly KY1044) - Anti-ICOS Monoclonal Antibody

Alomfilimab - Model SAR445256 (Formerly KY1044) - Anti-ICOS Monoclonal Antibody

Manufactured by:Kiadis Pharma NV   based inAmsterdam, NETHERLANDS
Alomfilimab SAR445256 (formerly KY1044) is a human monoclonal IgG1 that selectively binds to Inducible T cell CO-stimulator (ICOS), a protein expressed at high levels on immunosuppressive regulatory T cells and at lower levels on effector T cells. Alomfilimab is designed to exert anti-tumour activity through preferential depletion of intra-tumoral regulatory T ...
CONTACT SUPPLIER

Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Manufactured by:MorphoSys AG   based inPlanegg, GERMANY
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a histone protein, leading to the suppression of gene expression. Some cancers depend on an abnormal pattern of gene expression and re-direct EZH2 to genes ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT